Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NBR POLSKA TOMASZ KŁODAWSKI

Verified siteinfo

Poland Aleja Wincentego Witosa 31,, CH Panorama, Office Building, 00-710 Warsaw, Poland

  • 1 trial recruiting
  • Obesity · Type 2 diabetes mellitus
  • Adult patients

About Specializations

NBR POLSKA TOMASZ KŁODAWSKI in Warsaw, Poland specialises in clinical trials of conditions such as Obesity, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases

The site concentrates on Nutritional and Metabolic Diseases, with particular attention to Chronic Weight Management and Type 2 Diabetes Mellitus. Ongoing studies are designed to test innovative therapies that improve glucose regulation and promote lasting weight reduction.

  • Evaluation of dose‑response effects on glucose control
  • Investigation of long‑term influence on body weight
  • Safety and tolerability profiling of a novel GLP‑1 analogue
  • Extension studies to monitor durability of treatment benefits

Research is carried out at NBR POLSKA TOMASZ KŁODAWSKI in Warsaw, offering a dedicated environment for advancing metabolic health interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Aleja Wincentego Witosa 31,, CH Panorama, Office Building00-710 WarsawPoland
Open in maps ↗
Recruiting now
1 trial
Conditions studied
2
Partner status
Verified site

More sites in WarsawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Obesity

Recruiting

Long‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Type 2 diabetes mellitus

Not recruiting

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.